United Kingdom · Question · Written question
UIN 179602
Coronavirus: Vaccination
Introduced
12 April 2021
Last action
15 April 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 April 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) importance of the OCTAVE trial and the timescale for its preliminary and full results for people who are clinically extremely vulnerable immunosuppressed and
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 April 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) importance of the OCTAVE trial and the timescale for its preliminary and full results for people who are clinically extremely vulnerable immunosuppressed and
Source: Commons
15 April 2021
Answer
This OCTAVE study will provide important insights into the effectiveness of COVID-19 vaccines in clinically at-risk groups. This includes COVID-19 vaccine responses in patients with certain immunosuppressed conditions, including those with inflammatory di...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-04-12/179602
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1307228
- uk · wq-1307228 · source updated 15 April 2021